Search results
Gut Bacteria Slip into the Eye
The Scientist· 18 hours agoThe retina is layered with photoreceptors, a variety of other neurons, and protective and structural membranes, but retinal disorders can tamper with this delicate system. Mutations in the Crumbs ...
Santa J. Ono, University of Michigan President, Joins USJF Board
FOX 23 News Albany· 2 days agoSanta J. Ono, president of the University of Michigan, has joined the United States-Japan Foundation...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 7 days agoBEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization
HC Wainwright Reaffirms “Buy” Rating for Lineage Cell Therapeutics (NYSEAMERICAN:LCTX)
ETF DAILY NEWS· 24 hours agoHC Wainwright reissued their buy rating on shares of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Free Report) in a research report report published on Monday, Benzinga reports. The firm currently ...
Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
Benzinga· 3 days agoThe data demonstrated that Duravyu has a biologic effect in patients with NPDR and a favorable safety and tolerability profile; however, the trial did not meet the pre-specified primary endpoint ...
EyePoint Pharmaceuticals stock target cut, retains Buy rating By Investing.com
Investing.com· 3 days agoThe reduction follows a significant 43% drop in EyePoint's share value on Monday, which contrasted...
Head to Head Survey: Cognition Therapeutics (NASDAQ:CGTX) vs. Opthea (NASDAQ:OPT)
ETF DAILY NEWS· 5 days agoCognition Therapeutics (NASDAQ:CGTX – Get Free Report) and Opthea (NASDAQ:OPT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the ...
Baby Boomers' 14 Least Favorite Drug Brands: Ranked
247wallst.com· 1 day agoBaby boomers are currently one of the oldest demographics. For this reason, they’re also some of the most familiar with medications. But with so many...
Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
Zacks· 3 days agoFree Report) incurred a first-quarter 2024 loss of 54 cents per share, which matched the Zacks Consensus Estimate. Total revenues amounted to $172.3 million in the reported quarter, beating ...
Nanoscope Therapeutics Announces Presentations in Upcoming ASGCT Annual Meeting and Retina World...
FOX 5 San Diego· 3 days agoDALLAS, May 7, 2024 /PRNewswire/ -- Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative diseases, today announced that ...
